BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 54 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $209,000 | -10.3% | 180,000 | 0.0% | 0.00% | – |
| Q4 2015 | $233,000 | 0.0% | 180,000 | 0.0% | 0.00% | – |
| Q3 2015 | $233,000 | -16.2% | 180,000 | 0.0% | 0.00% | – |
| Q2 2015 | $278,000 | -33.5% | 180,000 | -35.7% | 0.00% | -100.0% |
| Q1 2015 | $418,000 | -35.6% | 280,000 | -49.1% | 0.00% | 0.0% |
| Q4 2014 | $649,000 | – | 550,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 12,643,000 | $13,010,000 | 6.81% |
| Ferox Capital Management LP | 5,000,000 | $5,134,000 | 3.58% |
| CQS Cayman LP | 26,000,000 | $26,836,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 59,076,000 | $60,714,000 | 1.19% |
| BASSO CAPITAL MANAGEMENT, L.P. | 4,825,000 | $4,948,000 | 0.92% |
| RWC Asset Management LLP | 5,250,000 | $5,397,000 | 0.28% |
| MACKAY SHIELDS LLC | 39,006,000 | $39,954,000 | 0.25% |
| CSS LLC/IL | 2,500,000 | $2,571,000 | 0.13% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,234,000 | $3,319,000 | 0.11% |
| Baker Brothers Advisors | 12,228,000 | $12,537,000 | 0.11% |